A phase I clinical trial of the sequential combination of irinotecan followed by flavopiridol.
Shah MA, Kortmansky J, Motwani M, Drobnjak M, Gonen M, Yi S, Weyerbacher A, Cordon-Cardo C, Lefkowitz R, Brenner B, O'Reilly E, Saltz L, Tong W, Kelsen DP, Schwartz GK.
Shah MA, et al. Among authors: tong w.
Clin Cancer Res. 2005 May 15;11(10):3836-45. doi: 10.1158/1078-0432.CCR-04-2651.
Clin Cancer Res. 2005.
PMID: 15897584
Clinical Trial.